Proveca Ltd
Peter McBride has extensive experience in the field of regulatory affairs, spanning over 20 years. Peter is currently the Head of Regulatory Affairs at Proveca Ltd since January 2017. Prior to this, they worked at Ipsen from 2011 to 2017, where they held the position of Regulatory Manager / Head of Quality Regulatory team at Ipsen BioPharma Limited, Wrexham. Before that, they served as the Regulatory Affairs Manager at ViroPharma Incorporated from April 2010 to January 2011 and as a Senior Regulatory Affairs professional at Teva Pharmaceuticals from September 2009 to April 2010.
Peter's expertise in regulatory affairs also includes their time at Novartis Vaccines, where they held the role of Ad interim Global Head Regulatory Compliance and Regulatory Affairs Manager from July 2008 to September 2009, and as a Regulatory Affairs Manager from January 2004 to July 2008. Earlier in their career, they served as a Senior Regulatory Affairs Executive at Chiron Corporation from February 2001 to December 2003.
Peter started their career at GlaxoSmithKline in 1999 as a Regulatory Compliance Executive before moving to GlaxoWellcome as a Regulatory Affairs Industrial Trainee from August 1996 to September 1997.
Throughout their career, Peter McBride has gained comprehensive knowledge and expertise in regulatory affairs, making him a valuable asset in the field.
From 1994 to 1998, Peter McBride attended the University of Leeds and obtained a Bachelor of Science (Honours) degree with a 2.1 grade. Peter'smajor was Pharmacology, with a minor in Management Studies. During this time, they also received a Certificate in Industry with Glaxo Wellcome.
Later, from 2002 to 2004, Peter McBride studied at Cardiff University / Prifysgol Caerdydd, where they earned a Certificate in Regulatory Affairs. This qualification was awarded by TOPRA (The Organisation for Professionals in Regulatory Affairs).
Based on the provided information, it can be concluded that Peter McBride has completed their education at these two institutions in the fields of Pharmacology, Management Studies, and Regulatory Affairs.
This person is not in any teams
Proveca Ltd
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit froma period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently.Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.